Hanlim Pharm Co., Ltd.
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 1989-03-14
- Employees
- 251
- Market Cap
- -
- Website
- http://hanlim.com
To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions
Phase 2
Completed
- Conditions
- Breast Diseases
- Interventions
- Drug: LuminoMark inj. 0.1mLDrug: LuminoMark inj. 0.2mLDrug: Charcotrace Inj.
- First Posted Date
- 2018-11-16
- Last Posted Date
- 2019-06-06
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 44
- Registration Number
- NCT03743259
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2018-08-31
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 272
- Registration Number
- NCT03655210
- Locations
- π°π·
Seoul National University Hospital, Gyeonggi-do, Korea, Republic of
A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis Patients
Phase 3
Completed
- Conditions
- Acute Bronchitis
- Interventions
- Drug: HL301(Experimental)Drug: Umkamin(Active Comparator)
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2019-02-12
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 246
- Registration Number
- NCT03654196
- Locations
- π°π·
Kyung Hee University Hospital, Seoul, Dongdaemun-gu, Korea, Republic of
A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of HL217 Eye Drop in Healthy Male Subjects
Phase 1
Completed
- Conditions
- Healthy Subject
- Interventions
- Drug: Placebo Ophthalmic solution
- First Posted Date
- 2018-08-29
- Last Posted Date
- 2019-04-01
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT03650608
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)
Phase 1
Completed
- Conditions
- Healthy Male Subjects
- Interventions
- Drug: Lodivixx tab. 5/160mg
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2018-08-27
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 27
- Registration Number
- NCT03648333
A Dose-escalation Clinical Trial After Multiple Dosing of HL217 Eye Drop in Healthy Male Subjects
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- Drug: Placebo
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2019-03-29
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT03648346
- Locations
- π«π·
Eurofins OPTIMED, Gières, France
A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia
Phase 3
Completed
- Conditions
- Complex-dyslipidemia
- Interventions
- Drug: HL-PIF cap.160/2mg + Placebo
- First Posted Date
- 2018-08-07
- Last Posted Date
- 2018-08-07
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 347
- Registration Number
- NCT03618797
Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia
Phase 3
Completed
- Conditions
- Primary Hypercholesterolemia
- Interventions
- Drug: HL140 5/10Drug: HL140 10/10Drug: HL140 20/10
- First Posted Date
- 2018-06-27
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 374
- Registration Number
- NCT03571087
Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus
- First Posted Date
- 2017-10-23
- Last Posted Date
- 2018-08-28
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 189
- Registration Number
- NCT03317301
- Locations
- π°π·
Hanyang Univ. Guri Hospital, Guri-si, Kyeonggi-do, Korea, Republic of
A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis Patients
- First Posted Date
- 2017-10-16
- Last Posted Date
- 2017-10-16
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Target Recruit Count
- 168
- Registration Number
- NCT03309800
- Locations
- π°π·
Kyung Hee University Hospital, Seoul, Dongdaemun-gu, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath